Given their glucose-lowering effects, GLP-1s have become standard of care for type 2 diabetes, supplanting other medication classes such as sulfonylureas.2 In 2023, GLP-1s represented 63% of diabetes spend, up from 38% in 2020.2 While diabetes GLP-1s will continue to account for a greater portion of spend compared to obesity, costs related to GLP-1s prescribed for obesity are expected to grow at a faster rate over the next 3 years
Some studies have shown important Zn depletion in patients with cirrhosis13 and 95% of cirrhotic patients with a MELD score equal to or above 15 points are estimated to have Zn deficiency,14 which correlates with the greater incidence of encephalopathy in those patients
They neutralize stomach acid, causing a reduction in gas production
10.1136/gutjnl-2013-305112 31
The endogenous ligand was finally identified in 1999 by Kojima and colleagues: ghrelin, a 28-amino-acid peptide produced mainly by the stomach
A complete Certificate of Analysis should show an HPLC result with a single dominant peak at the stated purity, a mass-spectrometry result confirming the molecular weight matches the intended compound, a bacterial endotoxin result from the Limulus Amebocyte Lysate (LAL) assay, the batch or lot number, and the name of an independent testing laboratory with a recent date
